NCT05913414View on ClinicalTrials.gov

Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal Carcinoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 5, 2023

Primary Completion Date

May 30, 2024

Study Completion Date

May 30, 2026

Conditions
Nasopharyngeal CarcinomaIron-deficiencyAnemia
Interventions
DRUG

Iron Isomaltoside 1000

Patients receive Iron isomaltoside after IC and CCRT

DRUG

Polysaccharide Iron Complex Pill

Patients receive Polysaccharide Iron Complex Pill after IC and CCRT

RADIATION

Intensity-modulated radiotherapy

All patients received intensity-modulated radiotherapy before enrolled.

Trial Locations (1)

510060

RECRUITING

Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER